Showing results (111-120 of 941) with videos related to
Sort By:
Pageof 95
Neurology and Therapy|October 3, 2020
An Evidence-Based Review of Galcanezumab for the Treatment of MigraineIvan Urits, Melis Yilmaz, Karina Charipova, et al.Neurology and Therapy|November 27, 2020
Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple SclerosisEdward E Neuberger, Ibrahim M Abbass, Eddie Jones, et al.Neurology and Therapy|October 31, 2021
Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be UsefulCarlo Avolio, Diego CentonzeNeurology and Therapy|May 2, 2022
White Matter and Alzheimer's Disease: A Bidirectional Mendelian Randomization StudyYaqing Li, Jiaxin Zheng, Tian Li, et al.Neurology and Therapy|April 5, 2022
Clinical Characteristics and Prognostic Significance of Subclinical Seizures in Focal Epilepsy: A Retrospective StudyChenmin He, Cong Chen, Yuyu Yang, et al.Neurology and Therapy|February 6, 2016
On Gelsemium and Complementary and Alternative Medicine (CAM) in Anxiety and Experimental NeurologySalvatore ChirumboloNeurology and Therapy|February 6, 2016
Concurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case-Control StudyJean-Pascal Fournier, Machelle Wilchesky, Valérie Patenaude, et al.Neurology and Therapy|April 18, 2016
Cognitive Profile of Zonisamide and Valproic Acid in the Treatment of Idiopathic Generalized Epilepsy: A Comparative Observational StudyTeresa Ramirez-García, Pedro J Serrano-Castro, Enrique Alonso-Morillejo, et al.Neurology and Therapy|July 23, 2017
Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New TechnologiesLih-Fen Lue, Andre Guerra, Douglas G WalkerNeurology and Therapy|July 23, 2017
A Review of Biomarkers for Alzheimer's Disease in Down SyndromeNi-Chung Lee, Yin-Hsiu Chien, Wuh-Liang HwuPageof 95